Stockreport

Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies [Yahoo! Finance]

Clearmind Medicine Inc.  (CMND) 
PDF the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therape [Read more]